6533b82dfe1ef96bd1291e17

RESEARCH PRODUCT

Development and implementation of the AIDA international registry for patients with Schnitzler's syndrome.

Jurgen SotaAntonio VitaleEwa Więsik-szewczykMicol FrassiGiuseppe LopalcoGiacomo EmmiMarcello GovoniAmato De PaulisAchille MarinoAntonio GidaroSara MontiDaniela Opris-belinskiRosa Maria R. PereiraKarina Jahnz-rózykCarla GaggianoFrancesca CrisafulliFlorenzo IannoneIrene MattioliFrancesca RuffilliIlaria MormileKatarzyna RybakValeria CaggianoPaolo AiròAbdurrahman TufanStefano GentileschiGaafar RagabIbrahim A. AlmaghlouthAdham Aboul-fotouh KhalilMarco CattaliniFrancesco La TorreMaria TarsiaHenrique A. Mayrink GiardiniMoustafa Ali SaadMonica BocchiaFederico CaroniTeresa GianiElisa CinottiPiero RuscittiPietro RubegniMarília A. DagostinBruno FredianiAslihan Avanoglu GulerFrancesca Della CasaMaria Cristina MaggioAndreas ReckeDagmar Von BubnoffKaroline KrauseAlberto BalistreriClaudia FabianiDonato RiganteLuca Cantarini

subject

RegistrySettore MED/38 - Pediatria Generale E SpecialisticaSchnitzler syndromeSettore MED/16 - REUMATOLOGIAautoinflammatory diseasebiotherapiesbiotherapierare diseaseGeneral Medicineautoinflammatory disease; biotherapies; interleukin-1; international registry; personalized medicine; rare diseasepersonalized medicineinternational registryinterleukin-1

description

ObjectiveThe present paper describes the design, development, and implementation of the AutoInflammatory Disease Alliance (AIDA) International Registry specifically dedicated to patients with Schnitzler's syndrome.MethodsThis is a clinical physician-driven, population- and electronic-based registry implemented for the retrospective and prospective collection of real-life data from patients with Schnitzler's syndrome; the registry is based on the Research Electronic Data Capture (REDCap) tool, which is designed to collect standardized information for clinical research, and has been realized to change over time according to future scientific acquisitions and potentially communicate with other existing or future similar registries.ResultsSince its launch, 113 centers from 23 countries in 4 continents have been involved. Fifty-seven have already obtained the approval from their local Ethics Committees. The platform counts 324 users (114 Principal Investigators, 205 Site Investigators, 2 Lead Investigators, and 3 data managers) at current (April 28th, 2022). The registry collects baseline and follow-up data using 3,924 fields organized into 25 instruments, including patient's demographics, history, clinical manifestations and symptoms, trigger/risk factors, laboratory, instrumental exams, therapies, socioeconomic information, and healthcare access.ConclusionsThis International Registry for patients with Schnitzler's syndrome facilitates standardized data collection, enabling international collaborative projects through data sharing and dissemination of knowledge; in turn, it will shed light into many blind spots characterizing this complex autoinflammatory disorder.

10.3389/fmed.2022.931189https://pubmed.ncbi.nlm.nih.gov/35924038